m (Amicchan moved page Pfizer. Inc to Pfizer Inc.: Typo.) |
mNo edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 32: | Line 32: | ||
| footnotes = <ref name=10K>{{Citation|title-url=https://s28.q4cdn.com/781576035/files/doc_financials/2021/ar/PFE-2021-Form-10K-FINAL.pdf |title=Pfizer Inc. 2021 Form 10-K Annual Report |publisher=Pfizer Inc.}}</ref> | | footnotes = <ref name=10K>{{Citation|title-url=https://s28.q4cdn.com/781576035/files/doc_financials/2021/ar/PFE-2021-Form-10K-FINAL.pdf |title=Pfizer Inc. 2021 Form 10-K Annual Report |publisher=Pfizer Inc.}}</ref> | ||
}} | }} | ||
'''Pfizer Inc.''' is a global pharmaceutical corporation. | '''Pfizer Inc.''' is a global pharmaceutical corporation. | ||
==Violations== | ==Violations== | ||
===Fraudulent Marketing=== | |||
On September 2, 2009, Pfizer was sued for $2.3 billion by the [[United States of America|U.S]] government for fraudulent marketing of multiple products.<ref name='DoJ Healthcare Fraud Entry'>{{Citation|title=Justice Department Announces Largest Health Care Fraud Settlement in Its History|title-url=https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history|author=Office of Public Affairs - Department of Justice}}</ref> | |||
Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica; and illegal bribery of hospitals to promote these drugs.<ref name='DoJ Healthcare Fraud Entry' /> | |||
===Nonconsensual Human Experimentation=== | |||
In the Abdullahi v. Pfizer, Inc lawsuit; Pfizer was found to have conducted unconsensual testing, with trovafloxacin, on 200 [[Nigeria|nigerian]] children. The lead investigator, Abdulhamid Isa Dutse, later provided a letter of approval for human trials that was found to be falsified.<ref>{{Citation|author=J. Wise|title=Pfizer accused of testing new drug without ethical approval|journal=BMJ (Clinical Research Ed.)|volume=322|issue=7280|pages=194|year=2001|pmid=11159610|pmc=1119465|doi=10.1136/bmj.322.7280.194}}</ref> | |||
In 2007, the government of Nigeria sued Pfizer for $6.95 billion as a result of this case.<ref>{{Web citation|url=https://www.business-humanrights.org/en/latest-news/nigerian-state-sues-pfizer-over-deformity-drug/|title=Nigerian state sues Pfizer over 'deformity' drug|date=2007-05-20|newspaper=Agence France Presse}}</ref> | |||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Drug companies]] | |||
Latest revision as of 16:06, 17 September 2022
Pfizer Inc. | |
|---|---|
 | |
| Industry |
|
| Key people | Albert Bourla (CEO) |
| Revenue | + $81.29 billion[1] |
| Net income | + $21.98 billion[1] |
| Website | |
| pfizer.com | |
[1] | |
Pfizer Inc. is a global pharmaceutical corporation.
Violations
Fraudulent Marketing
On September 2, 2009, Pfizer was sued for $2.3 billion by the U.S government for fraudulent marketing of multiple products.[2]
Pfizer bribed the U.S government for $1 billion to resolve allegations under the False Claims Act of illegal promotion of the drugs: Bextra, Geodon, Zyvox, and Lyrica; and illegal bribery of hospitals to promote these drugs.[2]
Nonconsensual Human Experimentation
In the Abdullahi v. Pfizer, Inc lawsuit; Pfizer was found to have conducted unconsensual testing, with trovafloxacin, on 200 nigerian children. The lead investigator, Abdulhamid Isa Dutse, later provided a letter of approval for human trials that was found to be falsified.[3]
In 2007, the government of Nigeria sued Pfizer for $6.95 billion as a result of this case.[4]
References
- ↑ 1.0 1.1 1.2 Pfizer Inc. 2021 Form 10-K Annual Report. Pfizer Inc..
- ↑ 2.0 2.1 Office of Public Affairs - Department of Justice. Justice Department Announces Largest Health Care Fraud Settlement in Its History.
- ↑ J. Wise (2001). Pfizer accused of testing new drug without ethical approval. BMJ (Clinical Research Ed.), vol.322 (p. 194). doi: 10.1136/bmj.322.7280.194 [HUB]
- ↑ "Nigerian state sues Pfizer over 'deformity' drug" (2007-05-20). Agence France Presse.